Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

(Yicai) Jan. 3 -- US pharmaceutical company Gilead Sciences has been given the greenlight by Chinese regulators to sell its ...

Gilead Sciences said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop programs to treat ...

TCW Funds, an investment management company, released its “TCW Relative Value Large Cap Fund” Q3 2024 investor letter. A copy ...

With cases of Feline Infectious Peritonitis (FIP) on rise in China, cat owners are making their pets pop in Covid-19 drugs as ...

China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication ...

Gilead abandoned testing of the antibody in ... the drug is still in clinical development in China. Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar ...

Lenacapavir for Alzheimer’s, an orca attacking a shark, and a moon landing are set to mark key scientific and technological ...

Gilead has won another victory in a wide-ranging ... fallen more than 8% on speculation about an anti-corruption probe in China, its second-largest market, wiping around $14 billion off its ...

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of ...